[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-370035-105":59,"doc-detail-370035-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","srsf9-mediates-oncogenic-rna-splicing-of-slc37a4-via-liquidliquid-phase-separation-to-promote-oral-cancer-progression","SRSF9 mediates oncogenic RNA splicing of SLC37A4 via liquid–liquid phase separation to promote oral cancer progression","","Oral cancer progresses through dysregulated post-transcriptional control, and this study investigates how SRSF9 influences oncogenic RNA processing of SLC37A4. SLC37A4 undergoes pronounced exon 7 skipping in oral cancer tissues, producing an oncogenic isoform, SLC37A4-S, linked to poor prognosis and increased proliferation and metastasis versus the wild-type isoform SLC37A4-L. SRSF9 can undergo liquid–liquid phase separation via its RS domain and regulates this aberrant splicing, with disruption of LLPS reducing its regulatory effects. Both SRSF9 and SLC37A4-S contribute to cisplatin chemotherapy resistance in oral cancer cells, supporting therapeutic target potential.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/srsf9-mediates-oncogenic-rna-splicing-of-slc37a4-via-liquidliquid-phase-separation-to-promote-oral-cancer-progression/370035/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/srsf9-mediates-oncogenic-rna-splicing-of-slc37a4-via-liquidliquid-phase-separation-to-promote-oral-cancer-progression/370035.png","ImageObject",300,407,{"name":92,"@type":93},"dhado","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What key splicing change occurs in oral cancer for SLC37A4?","Question",{"text":112,"@type":113},"SLC37A4 shows significant exon 7 skipping in oral cancer tissues, generating the oncogenic splicing isoform SLC37A4-S.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does SRSF9 contribute to SLC37A4 aberrant splicing?",{"text":117,"@type":113},"SRSF9 undergoes liquid–liquid phase separation and regulates the aberrant splicing of SLC37A4 exon 7 through this phase-separated state.",{"name":119,"@type":110,"acceptedAnswer":120},"Does SLC37A4-S affect oral cancer treatment response?",{"text":121,"@type":113},"Yes. SRSF9 and its regulated SLC37A4-S splicing isoforms contribute to cisplatin chemotherapy resistance in oral cancer.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},370035,1790665140,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},5909893218464,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Journal of Advanced Research 79 (2026) 505–520  \nContents lists available at ScienceDirect  \nJournal of Advanced Research  \njournal [homepage: www. elsevier. com/locate/jare](homepage: www. elsevier. com/locate/jare)  \nSRSF9 mediates oncogenic RNA splicing of SLC37A4 via liquid–liquid phase separation to promote oral cancer progression  \nQiu Peng a,b, 1, Lujuan Wang c, 1, Ying Long a, 1, Hao Tian a,b, Xuemeng Xu a,b, Zongyao Ren a,b, Yaqian Han a,b, Xianjie Jiang a,b, Zhu Wu a,b, Shiming Tan a, Wenjuan Yang a, Linda Oyang a,b, Xia Luo a,b, Jinguan Lin a,b, Longzheng Xia a,b, Mingjing Peng a,b, Nayiyuan Wu a,b, Yanyan Tang a,b, Qianjin Liaod,⁎, Yujuan Zhou a,b,c,⁎⁎  \na The Afﬁliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Hunan Key Laboratory of Cancer Metabolism, Changsha 410013 Hunan, China  \nb Hunan Engineering Research Center of Tumor Organoid Technology and Application, Public Service Platform of Tumor Organoids Technology, 283 Tongzipo Road, Changsha 410013 Hunan, China  \nc Hunan Key Laboratory of Tumor Models and Individualized Medicine, The Second Xiangya Hospital of Central South University, Changsha 410011 Hunan, China d Department of Oncology, Hunan Provincial People’s Hospital, The First Afﬁliated Hospital of Hunan Normal University, Changsha 410005 Hunan, China  \nh i g h l i g h t s  \n• SLC37A4 undergoes a signiﬁcant exon 7 skipping in oral cancer tissues, generating an oncogenic splicing isoform SLC37A4-S.  \n• SLC37A4-S isoform signiﬁcantly augments the proliferation and metastatic potential of oral cancer cells.  \n• SRSF9 can undergo liquid–liquid phase separation (LLPS) and regulate aberrant splicing of SLC37A4 exon 7.  \n• SRSF9 and its regulated splicing isoforms of SLC37A4-S contribute tocisplatin chemotherapy resistance in oral cancer.  \ng r a p h i c a l a b s t r a c t  \nSchematic representation of the possible mechanism of SRSF9 phase separation-mediated alternative splicing of SLC37A4 in the malignant progression of oral cancer.  \na r t i c l e i n f o  \nArticle history:  \nReceived 17 January 2025 Revised 3 March 2025  \nAccepted 6 March 2025  \nAvailable online 8 March 2025  \nKeywords: Oral cancer  \na b s t r a c t  \nIntroduction: Oral cancer represents a signiﬁcant proportion of head and neck malignancies, accounting for approximately 3 % of all malignant tumors worldwide.  \nObjectives: Alternative splicing (AS), a post-transcriptional regulatory mechanism, is increasingly linked to cancer development. The precise impact of AS on oral cancer progression is not well understood. Methods: Bioinformatics, semi-quantitative RT-PCR, and minigene reporter system to detect the skipping of SLC37A4 exon 7 in oral cancer. FRAP, live cell immunoﬂuorescence demonstrates that SRSF9 can undergo liquid–liquid phase separation (LLPS). In vivo and in vitro experiments with subcutaneous graft  \n⁎ Corresponding author.  \n⁎⁎ Corresponding author at: The Afﬁliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Hunan Key Laboratory of Cancer Metabolism, Changsha 410013, Hunan, PR China.  \nE-mail [addresses:](addresses: march-on@126.com)[ march-on@126.com](addresses: march-on@126.com) (Q. Liao), [yujany_zhou@163.com](yujany_zhou@163.com) (Y. Zhou).  \n1 These authors contributed equally to this work.  \n[https://doi.org/10.1016/j.jare.2025.03.013](https://doi.org/10.1016/j.jare.2025.03.013)  \n2090-1232/© 2025 The Authors. Published by Elsevier B.V. on behalf of Cairo University.  \nThis is an open access article under the CC BY-NC-ND license ([http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/)).  \nQ. Peng, L. Wang, Y. Long et al. Journal of Advanced Research 79 (2026) 505–520  \nAlternative splicing SRSF9  \nSLC37A4  \nLiquid–liquid phase separation  \ntumors, CCK8, EdU, transwell, and others were used to detect the effects of SRSF9 and its induced SLC37A4-S isoforms on the malignant ","cbCaicygZ0BFXRr4","https://ap.wps.com/l/cbCaicygZ0BFXRr4","pdf",7538833,16,"English","# Introduction\n# Objectives\n# Methods\n# Results\n# Conclusion","[{\"question\":\"What key splicing change occurs in oral cancer for SLC37A4?\",\"answer\":\"SLC37A4 shows significant exon 7 skipping in oral cancer tissues, generating the oncogenic splicing isoform SLC37A4-S.\"},{\"question\":\"How does SRSF9 contribute to SLC37A4 aberrant splicing?\",\"answer\":\"SRSF9 undergoes liquid–liquid phase separation and regulates the aberrant splicing of SLC37A4 exon 7 through this phase-separated state.\"},{\"question\":\"Does SLC37A4-S affect oral cancer treatment response?\",\"answer\":\"Yes. SRSF9 and its regulated SLC37A4-S splicing isoforms contribute to cisplatin chemotherapy resistance in oral cancer.\"}]","SRSF9 mediates oncogenic RNA splicing of SLC37A4 via liquid–liquid phase separation to promote oral cancer progression | PDF",1790186366,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3097e57b9c05e8e4561b9b76248b1010.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/331cb5427c4550c8090ebd68fea840f9.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/138cfa7aeadf7f234fa9869f5b87cd2b.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/934ab4497f50f294e0670cfab82b4030.webp",980,1306]